Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,75,1.01 [0.99-1.03],0.542037071477408
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,75,1.02 [1.00-1.04],0.0640767784574163
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,75,1.00 [0.98-1.02],0.972170854363223
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,75,1.15 [0.93-1.43],0.194196526952908
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,75,1.00 [0.97-1.04],0.820200147847996
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,75,0.83 [0.63-1.10],0.204820536942778
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,75,1.01 [0.91-1.12],0.853611423669419
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,75,1.07 [0.92-1.24],0.389076482847389
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,75,1.00 [0.96-1.03],0.899519537005676
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,75,0.99 [0.96-1.02],0.598136523261737
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,75,0.99 [0.93-1.05],0.68026740435419
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,75,0.99 [0.91-1.07],0.742712978741867
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,75,0.95 [0.90-1.00],0.0623207232798588
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,75,0.97 [0.90-1.04],0.365895510913094
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,75,1.02 [0.88-1.20],0.763500672255912
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,75,0.95 [0.87-1.03],0.230099624025106
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,Inverse variance weighted,75,0.99 [0.92-1.05],0.675424937227571
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,75,0.96 [0.89-1.03],0.255028906687149
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,75,0.93 [0.87-1.00],0.0353670491003827
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,75,0.96 [0.93-1.00],0.0257489010437188
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,75,1.03 [0.96-1.10],0.378380013423217
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,75,0.96 [0.88-1.05],0.380353385936657
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,75,0.96 [0.91-1.01],0.101021409641286
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,75,0.98 [0.96-1.00],0.0148784225518236
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,75,0.93 [0.87-1.00],0.0384575373412826
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,75,0.99 [0.97-1.01],0.253437964921952
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,75,1.01 [0.99-1.03],0.608261028984536
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,75,1.01 [1.00-1.03],0.055595794072443
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,75,0.96 [0.91-1.00],0.0758349242934245
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,75,0.99 [0.96-1.01],0.22078925801173
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,75,0.98 [0.92-1.05],0.587555043357001
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,75,1.01 [0.94-1.09],0.813937777693991
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,75,1.04 [1.00-1.08],0.0855071956616516
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,75,1.00 [0.98-1.03],0.832179824321835
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,75,0.97 [0.92-1.03],0.309096045658364
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,75,1.01 [0.99-1.02],0.5221552684452
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,75,1.00 [0.98-1.02],0.983033684256033
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,75,0.91 [0.73-1.15],0.436816443207807
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,75,0.99 [0.87-1.13],0.868156701164552
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,75,0.99 [0.96-1.01],0.295888238734198
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,75,0.94 [0.86-1.03],0.19068467517436
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,75,0.93 [0.83-1.03],0.172043205024242
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,75,0.94 [0.87-1.02],0.125874078310985
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,75,1.01 [0.91-1.12],0.837928254977624
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,75,0.98 [0.88-1.10],0.773489117392323
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,75,1.00 [0.95-1.05],0.966947506572189
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,75,0.98 [0.96-1.00],0.0226766536086246
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,75,0.99 [0.97-1.02],0.548413506810817
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,75,0.99 [0.96-1.02],0.4120583756834
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,75,0.96 [0.91-1.02],0.201574329190572
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,75,0.99 [0.83-1.19],0.937977903874025
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,75,1.00 [0.92-1.09],0.974479689678181
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,75,0.98 [0.97-1.00],0.0568198621805101
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,75,0.99 [0.96-1.03],0.644677868313815
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,Inverse variance weighted,75,1.04 [0.94-1.15],0.422656990194259
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,75,0.98 [0.95-1.00],0.0951498429417411
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,Inverse variance weighted,75,0.99 [0.95-1.02],0.411688381952915
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,75,1.02 [0.93-1.12],0.630991006704116
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,75,0.98 [0.95-1.01],0.175782850489083
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,75,0.97 [0.93-1.01],0.136221232008526
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,75,0.89 [0.82-0.96],0.0042272602022703
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,Inverse variance weighted,75,1.02 [0.93-1.10],0.719303399366183
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute peritonitis,Inverse variance weighted,75,0.97 [0.89-1.05],0.465033265331078
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,75,1.03 [0.99-1.08],0.166554235731354
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,75,1.02 [0.92-1.13],0.719754037807232
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,75,0.99 [0.97-1.02],0.608873899982431
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,Inverse variance weighted,75,0.97 [0.85-1.11],0.650619858611138
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,75,0.98 [0.96-1.01],0.126717453028513
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,75,0.99 [0.93-1.04],0.615908257330868
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,75,1.01 [0.98-1.04],0.466601130025354
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,Inverse variance weighted,75,0.98 [0.93-1.02],0.315847499190527
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,75,1.01 [0.97-1.05],0.786666275994095
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,75,0.98 [0.95-1.01],0.115927707629819
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,75,1.00 [0.97-1.02],0.857835059882525
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,Inverse variance weighted,75,1.00 [0.93-1.07],0.969011437209036
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,75,0.98 [0.95-1.02],0.266927652991423
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],Inverse variance weighted,75,0.98 [0.92-1.06],0.658512127158775
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,75,0.98 [0.96-1.00],0.0216909444337979
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,75,1.00 [0.96-1.05],0.946767790590331
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,75,0.95 [0.86-1.06],0.365880317549279
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,75,0.99 [0.95-1.03],0.467946732336163
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,75,1.06 [0.92-1.21],0.420725357696706
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,75,0.97 [0.92-1.03],0.339792204981137
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,75,1.01 [0.99-1.03],0.521353138267677
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,75,1.02 [0.95-1.09],0.560009098501711
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",Inverse variance weighted,75,1.03 [0.96-1.11],0.445409269613747
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,75,0.98 [0.95-1.00],0.0474278097227896
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,75,0.98 [0.96-1.00],0.0697926587811632
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,75,0.98 [0.92-1.04],0.458547664335466
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,75,0.97 [0.92-1.01],0.122922666110439
